Indivior Pharmaceuticals, Inc. Common Stock

$37.8
USD
Last updated on --.
24h volume1.65M
24h highest38.5800 USD
24h lowest37.4800 USD
24h Price movement+0.73%

INDV recent prices

24 Hours
+0.73%+$0.275
30 days
+9.75%+$3.345
60 days
+29.58%+$8.570
90 days
+11.70%+$3.945

Key data

Previous close37.5300 USD
Market cap4.44B USD
Volume1.65M
P/E ratio17.700000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)2.1200 USD
Net income (FY)251.00M USD
Revenue (FY)1.29B USD
Last report dateApr 30, 2026

About Indivior Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersNORTH CHESTERFIELD
Employees (FY)838.00
Revenue per employee (FY)1.54M USD
Net income per employee (FY)299.52K USD
Listed onNasdaq
Official website

INDV conversion tables

INDVINDV
USDUSD
0.5 INDV18.9 USD
1 INDV37.8 USD
5 INDV189.02 USD
10 INDV378.05 USD
USDUSD
INDVINDV
0.5 USD0.013226 INDV
1 USD0.026452 INDV
5 USD0.13226 INDV
10 USD0.26452 INDV

FAQ

INDV is trading at $37.80, +0.73% over the last 24 hours. Track live moves on the price chart at the top of this page.
The INDV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. INDV is currently trading at $37.80, +0.73% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on INDV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. INDV's P/E ratio is currently 17.700000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from INDV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against INDV's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Indivior Pharmaceuticals, Inc. Common Stock's market cap is currently 4.44B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.65M
24h highest38.5800 USD
24h lowest37.4800 USD
24h Price movement+0.73%
INDVINDV
USDUSD
Start trade with INDV Perpetual